Drugs / 9-valent Human Papillomavirus Vaccine (Escherichia Coli)
9-valent Human Papillomavirus Vaccine (Escherichia Coli)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07530679 | Apr 2026 → Jun 2027 expected | — | Jiangsu Province Centers for Disease Control and Prevention | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 9-valent Human Papillomavirus Vaccine (Escherichia Coli) | “A Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential Vaccination With 9-Valent Human Papillomavirus Vaccine (Escherichia...” NCT07530679 ↗ |
| Modality | Vaccine | “9-valent Human Papillomavirus Vaccine (Escherichia Coli)” NCT07530679 ↗ |